Confirm delete?

Bertin Bioreagent
logo
All categories
Contact Us
You are here :

EPI-001

  • Zoom
    EPI-001
  • EPI-001
Cat No: 16970
Biochemicals - Receptor Pharmacology
Cayman

EPI-001 is an androgen receptor antagonist with an IC50 value of approximately 6 μM for inhibition of transactivation of the androgen receptor N-terminal domain (NTD).{38581} It inhibits androgen-, FSK-, and IL-6-induced, as well as ligand-independent...

More

This product can only be bought through Cayman Chemical. Please contact us.

Territorial Availability: Available through Bertin Technologies only in France
Synonyms:
  • 3-[4-[1-[4-(3-chloro-2-hydroxypropoxy)phenyl]-1-methylethyl]phenoxy]-1,2-propanediol
Correlated keywords:
  • 882690-01-9 1297605-27-6 EPI001 ?H2O IL6 MDAPCa2B DU-145 PC-3 LT-313
Product Overview:
EPI-001 is an androgen receptor antagonist with an IC50 value of approximately 6 μM for inhibition of transactivation of the androgen receptor N-terminal domain (NTD).{38581} It inhibits androgen-, FSK-, and IL-6-induced, as well as ligand-independent, prostate-specific antigen (PSA) reporter gene expression in LNCaP cells expressing either the full length androgen receptor or a constitutively active mutant that lacks the ligand binding domain in a dose-dependent manner. EPI-001 inhibits androgen receptor interaction with the PSA androgen response element and blocks androgen-stimulated induction of endogenous PSA and 17 other androgen regulated genes in LNCaP cells. It inhibits androgen-dependent and -independent growth of LNCaP and MDA-PCa-2B cells, but not 22Rv1, DU145, or PC3 cells that do not express the androgen receptor. EPI-001 (50 mg/kg) reduces serum PSA and tumor growth in an LNCaP prostate cancer xenograft model in castrated mice. It also reduces serum PSA in a patient-derived LT313 prostate cancer mouse xenograft model. Formulations containing EPI-001 are under clinical investigation for the treatment of castration-resistant prostate cancer.
Size 5 mg
Shipping dry ice
CAS Number 227947-06-0
Molecular Formula C21H27ClO5
SMILES ClCC(O)COC(C=C1)=CC=C1C(C)(C)C2=CC=C(OCC(O)CO)C=C2
Molecular Weight 394,9
Formulation A crystalline solid
Purity ≥95%
Custom Code 2903.99
UNSPSC code 12352100

Click here to ask for your quote and get 15% off Cayman's products.

 

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

/ We also advise you

Cross selling for this product : EPI-001 There are 6 products.

Search